Device
Vigilant Diabetes Management Application
Vigilant Diabetes Management Application is a medical device with 3 clinical trials. Historical success rate of 33.3%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(67%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Terminated2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
terminated267%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
terminatednot_applicable
A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion
NCT02906891
terminatednot_applicable
T1 Diabetes Hypoglycemia Prevention Pilot
NCT02682940
completednot_applicable
Human Factors and Home Use Study of the Vigilant Diabetes Management Application
NCT02276131
Clinical Trials (3)
Showing 3 of 3 trials
NCT02906891Not Applicable
A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion
NCT02682940Not Applicable
T1 Diabetes Hypoglycemia Prevention Pilot
NCT02276131Not Applicable
Human Factors and Home Use Study of the Vigilant Diabetes Management Application
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3